Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center
Digestive Diseases · 2025
DOI: 10.1159/000549554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases, 2025. Verfasst von Niki Jud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology & Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Intestines, Crohn Disease, Colitis, Ulcerative. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Introduction
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are chronic immune-mediated disorders that significantly impact patients’ quality of life. Proper IBD management often requires invasive diagnostic procedures such as endoscopy. Transabdominal intestinal ultrasound (IUS) offers a promising alternative due to its noninvasive, inexpensive, and widely available nature. This study aimed to evaluate the effectiveness of IUS combined with clinical parameters in guiding treatment decisions for IBD patients in remission or relapse.
Methods
This is a retrospective cohort study of University Hospital Zurich (January–August 2022), which included consecutive adult IBD patients undergoing a single transabdominal IUS for treatment decision-making. IUS influenced clinical decisions by guiding therapy continuation, modification, or cessation and addressing complications.
Results
The study analyzed 103 consecutive IBD patients, 66% diagnosed with CD, and 34% with UC. The majority (69.9%) were in clinical remission, and two-third of the remission patients claimed also no symptoms (32% of the whole cohort were asymptomatic). Bowel wall thickness (BWT) in the terminal ileum and left colon also significantly influenced treatment decisions (p = 0.014 and p = 0.042, respectively). In a multivariable logistic regression, both diarrhea (p = 0.013) and maximal BWT (p = 0.020) remained statistically significant predictors for a change in treatment.
Conclusion
The study demonstrates that IUS, along with clinical symptoms such as diarrhea, plays a significant role in guiding treatment decisions for IBD patients. Diarrhea and BWT were strong predictors for adjusting therapy, highlighting the value of integrating noninvasive imaging with clinical assessment to optimize IBD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology & Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Department of General Internal Medicine, Community Hospital Waid, Zurich, Switzerland.
- Department of Hygiene, Social-Preventive Medicine & Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Gastroenterology & Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, gerhard.rogler@usz.ch.
- Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland.
Zitieren
APA
Jud, N., Biedermann, L., Kreienbuehl, A. S., Pagkalidou, E., Rogler, G., & Doulberis, M. (2025). Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center. Digestive Diseases. https://doi.org/10.1159/000549554
Vancouver
Jud N, Biedermann L, Kreienbuehl AS, Pagkalidou E, Rogler G, Doulberis M. Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center. Digestive Diseases. 2025. doi:10.1159/000549554
BibTeX
@article{Jud2025,
author = {Jud, Niki and Biedermann, Luc and Kreienbuehl, Andrea S and Pagkalidou, Eirini and Rogler, Gerhard and Doulberis, Michael},
title = {Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center},
journal = {Digestive Diseases},
year = {2025},
doi = {10.1159/000549554}
}
EUVIMED